Sign in
XCUR Stock Price, Chart, Stats & News
Exicure, Inc.
Save
Exicure, Inc. (XCUR) does not currently pay a dividend.
8.73M
Market cap
–
Current P/E
–
Forward P/E
XCUR chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 11.36% |
ROA | -35.23% |
ROE | -63.62% |
D/E | 0.04x |
Interest coverage ratio | -4207.00x |
XCUR valuation
P/E | – |
P/S | – |
P/B | 7.08x |
P/CF | -3.25x |
P/FCF | -1.93x |
P/OCF | -3.25x |
PEG | -0.11x |
EV multiple | -3.28x |
About
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas.
Similar securities
Based on sector and market capitalization
Report issue